Design Therapeutics, Inc. (DSGN)

NASDAQ: DSGN · IEX Real-Time Price · USD
11.40
0.34 (3.07%)
May 20, 2022 4:00 PM EDT - Market closed

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year202120202019
Revenue
00.230.83
Revenue Growth (YoY)
--72.90%-
Gross Profit
00.230.83
Selling, General & Admin
11.052.51.09
Research & Development
24.786.061.65
Operating Expenses
35.838.562.74
Operating Income
-35.83-8.33-1.91
Other Expense / Income
-0.3-0.050.14
Pretax Income
-35.53-8.28-2.05
Net Income
-35.53-8.28-2.05
Net Income Common
-35.53-8.28-2.05
Shares Outstanding (Basic)
461615
Shares Outstanding (Diluted)
461615
Shares Change
190.80%2.08%-
EPS (Basic)
-0.77-0.52-0.13
EPS (Diluted)
-0.77-0.52-0.13
Free Cash Flow Per Share
-0.67-0.55-0.01
Gross Margin
-100.00%100.00%
Operating Margin
--3685.84%-228.78%
Profit Margin
--3663.72%-245.44%
Free Cash Flow Margin
--3869.47%-16.67%
EBITDA
-35.4-8.28-2.05
EBITDA Margin
--3661.50%-245.44%
EBIT
-35.53-8.28-2.05
EBIT Margin
--3663.72%-245.44%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).